Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6. (Q64949263)
Jump to navigation
Jump to search
scientific article published in January 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6. |
scientific article published in January 1999 |
Statements
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6 (English)
Delgado M
Martinez C
Pozo D
Calvo JR
Leceta J
Ganea D